Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Dermatological Medicine
Volume 2018, Article ID 2354146, 4 pages
https://doi.org/10.1155/2018/2354146
Case Report

Upfront Radiotherapy with Concurrent and Adjuvant Vismodegib Is Effective and Well-Tolerated in a Patient with Advanced, Multifocal Basal Cell Carcinoma

1St. Joseph’s Hospital Health Center, 301 Prospect Avenue, Syracuse, NY 13203, USA
2Upstate University Hospital, 750 E. Adams Street, Syracuse, NY 13210, USA

Correspondence should be addressed to Abigail I. Franco; moc.liamg@321dmocnarf.liagiba

Received 25 September 2017; Revised 21 December 2017; Accepted 15 January 2018; Published 21 February 2018

Academic Editor: Alireza Firooz

Copyright © 2018 Abigail I. Franco et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Goldenberg, T. Karagiannis, J. B. Palmer et al., “Incidence and prevalence of basal cell carcinoma (BCC) and locally advanced BCC (LABCC) in a large commercially insured population in the United States: a retrospective cohort study,” Journal of the American Academy of Dermatology, vol. 75, no. 5, pp. 957–966.e2, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. N. W. J. Smeets, G. A. M. Krekels, J. U. Ostertag et al., “Surgical excision vs Mohs’ micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial,” The Lancet, vol. 364, no. 9447, pp. 1766–1772, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. M. K. Silverman, A. W. Kopf, C. M. Grin, R. S. Bart, and M. J. Levenstein, “Recurrence rates of treated basal cell carcinomas: part 1: overview,” The Journal of Dermatologic Surgery and Oncology, vol. 17, no. 9, pp. 713–718, 1991. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Piccinno, S. Benardon, F. M. Gaiani, M. Rozza, and M. Caccialanza, “Dermatologic radiotherapy in the treatment of extensive basal cell carcinomas: a retrospective study,” Journal of Dermatological Treatment, vol. 28, no. 5, pp. 426–430, 2017. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Sekulic, M. R. Migden, and A. E. Oro, “Efficacy and safety of vismodegib in advanced basal-cell carcinoma,” The New England Journal of Medicine, vol. 366, no. 23, pp. 2171–2179, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Locke, S. Karimpour, G. Young, M. A. Lockett, and C. A. Perez, “Radiotherapy for epithelial skin cancer,” International Journal of Radiation Oncology & Biology & Physics, vol. 51, no. 3, pp. 748–755, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. E. L. Pollom, T. T. Bui, A. L. Chang, A. D. Colevas, and W. Y. Hara, “Concurrent vismodegib and radiotherapy for recurrent, advanced basal cell carcinoma,” JAMA Dermatology, vol. 151, no. 9, pp. 998–1001, 2015. View at Publisher · View at Google Scholar
  8. J. M. Strasswimmer, “Potential synergy of radiation therapy with vismodegib for basal cell carcinoma,” JAMA Dermatology, vol. 151, no. 9, pp. 925-926, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. A. C. D. O. Gonzalez, Z. D. A. Andrade, T. F. Costa, and A. R. A. P. Medrado, “Wound healing—a literature review,” Anais Brasileiros de Dermatologia, vol. 91, no. 5, pp. 614–620, 2016. View at Publisher · View at Google Scholar · View at Scopus